Viewing Study NCT03303495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-01-22 @ 6:24 AM
Study NCT ID: NCT03303495
Status: UNKNOWN
Last Update Posted: 2017-10-06
First Post: 2017-09-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Neoplasms View
None Neoplasm Metastasis View
None Intestinal Neoplasms View
None Gastrointestinal Neoplasms View
None Digestive System Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None FOLFIRI View
None CPT-11 View
None Bevacizumab View
None 2nd-line metastatic colorectal cancer View